British Biotech Firm To Sell COVID-19-Focused Unit For $10M
By Dawood Fakhir ( January 2, 2025, 2:22 PM GMT) -- British biotech company Roquefort Therapeutics PLC said Thursday that it has agreed to sell its COVID-19-focused subsidiary to Pleiades Pharma Ltd. for at least $10 million three years after its acquisition....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.